Discussion on management strategies of multi-center pharmaceutical clinical study initiated by investigator
10.3760/cma.j.cn113565-20210122-00014
- VernacularTitle:研究者发起的多中心药物临床研究管理策略探讨
- Author:
Baoshi YUAN
1
;
Yinkai WANG
;
Xia MENG
Author Information
1. 首都医科大学附属北京天坛医院 国家神经系统疾病临床医学研究中心，北京 100070
- Keywords:
Investigator-Initiated Trial;
Multi-center pharmaceutical clinical study;
Management strategy;
Project management
- From:
Chinese Journal of Medical Science Research Management
2022;35(2):91-96
- CountryChina
- Language:Chinese
-
Abstract:
Objective:Discuss the problems of multi-center pharmaceutical clinical trial which initiated by investigator (IIT), providing references for developing study management strategies.Methods:By analyzing the site recruitment, academic and ethical review, study contract, study training, quality control, influencing factors of subject enrollment, proposed management strategies of multi-center pharmaceutical clinical study which initiated by investigator.Results:While conducting multi-center pharmaceutical clinical study initiated by investigator, the study experiences, study team, hospital equipment, and the internal process of hospitals are the factors which ensure the progress and quality of clinical study. Most of the sites have no clear statement of scientific review, but most of the high-level hospitals do not use the ethical review results of the head hospitals, the ethics must be reviewed repeatedly; Contract also has different requirements due to different management departments. During the preparation and implement of IIT, the investigators should undergo a rigorous training which is a key element to ensure the quality of the study. Research quality and progress restrict each other and are affected by many factors, detailed quality control measures should be developed, training and inspection, and the cooperation of project management and data management, also with discover the data problems of sites and communicate with investigators timely to ensure the improvement measures are implemented.Conclusions:There are many factors have impact on study progress and quality of multi-center pharmaceutical clinical trial of IIT. Before conducting research, protocols should be developed scientifically, and fully assessing its feasibility, screening study sites strictly, shorten the time of ethical review and contract preparation. Study training, inspection, data management, risk management and document management should be implement strictly, and make full use of information platforms and means, improve management efficiency and IIT progress and quality.
